Chester County News and Community Website
CONSHOHOCKEN, PA — Cencora Inc. (NYSE: COR) raised its fiscal 2026 earnings outlook after third-quarter revenue increased 5.1% to $84.8 billion and operating income climbed 29%, as growth in pharmaceutical …
Cencora Raises 2026 EPS Outlook as Quarterly Profit Climbs Read More CONSHOHOCKEN, PA — Good Neighbor Pharmacy ranked highest in customer satisfaction among chain drug store pharmacies in J.D. Power’s 2026 U.S. Pharmacy Study, giving Cencora’s independent-pharmacy franchise its 14th top …
Good Neighbor Pharmacy Tops J.D. Power Satisfaction Ranking Read More CONSHOHOCKEN, PA — Cencora Inc. (NYSE: COR) will report results for its third quarter of fiscal 2026 before the opening bell on Aug. 5, providing investors with an update on …
Cencora Sets Aug. 5 Earnings Release as Investors Watch Results Read More CONSHOHOCKEN, PA — Cencora is launching a multi-site pilot of an upgraded inventory management platform for specialty physician practices, a move aimed at helping providers manage increasingly complex and costly …
Cencora Tests Inventory Platform as Specialty Drug Demands Rise Read More CONSHOHOCKEN, PA — Cencora (NYSE: COR) has appointed former Verizon executive Samantha Hammock as chief human resources officer, bringing in an external leader to oversee workforce strategy for the pharmaceutical …
Cencora Names Verizon Executive as New HR Chief Read More CONSHOHOCKEN, PA — Cencora has entered an agreement with Kite, a unit of Gilead Sciences, to distribute two FDA-approved CAR T-cell cancer therapies across a growing network of treatment centers, …
Cencora, Kite Expand CAR-T Distribution Network as Access Grows Read More CONSHOHOCKEN, PA — Cencora (NYSE: COR) has appointed former CVS Health and Bath & Body Works executive Eva C. Boratto as chief financial officer, bringing in a veteran healthcare finance …
Cencora Names Former CVS, Bath & Body Works Executive CFO Read More CONSHOHOCKEN, PA — Cencora (NYSE: COR) raised its fiscal 2026 earnings outlook and authorized an additional $2 billion share repurchase program, signaling confidence in cash generation as the pharmaceutical distribution …
Cencora Raises Earnings Outlook, Expands Buyback Capacity Read More CONSHOHOCKEN, PA — Cencora reported higher second-quarter revenue and earnings for fiscal 2026 and raised its full-year adjusted earnings outlook, driven by growth in its U.S. and international healthcare distribution …
Cencora Raises Fiscal 2026 Outlook After Earnings Gain Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) will release its fiscal second-quarter 2026 results before the New York Stock Exchange opens on Wednesday, May 6, followed by a conference call …
Cencora Sets May 6 Date for Second-Quarter Earnings Release Read More